Fluidigm Corporation (NASDAQ:FLDM) today announced it has joined AMDeC (Academy for Medical Development and Collaboration) as a Vendor Partner. This will provide Fluidigm with easy access to almost 20 of the pre-eminent medical research institutions in the New York region through AMDeC’s unique online resource - AMDeC F.I.R.S.T. - while also providing preferred pricing on select Fluidigm products to all AMDeC Member institutions.
AMDeC F.I.R.S.T. (Facilities Instrumentation Resources Services & Technologies) is a powerful web-based platform and real-time registry that catalogs more than 1,000 services and instruments from across the AMDeC Member consortium. It serves as the portal to several AMDeC services, including the Vendor Partnership Program joined by Fluidigm. This program secures preferred vendor pricing agreements for all AMDeC Members. Benefits for Vendor Partners include facilitated access to researcher end users, research directors and other institutional decision makers, as well as closer working relationships with the academic research community.
AMDeC F.I.R.S.T. creates a virtual “laboratory” that can be leveraged by researchers for collaboration and shared use. It expands and extends the research resources of every Member institution, facilitating the sharing of resources, and delivering the potential to reduce or recover costs, achieve resource efficiencies, foster new collaborations and expedite discovery.
“Fluidigm is delighted to become a partner with the prestigious membership of AMDeC. Being a leader in single-cell analysis, we know that our technologies will enable AMDeC researchers to see cellular behaviors and processes that were previously hidden by using pooled samples,” said Dan Clutter, Ph.D., Sales Director, Eastern U.S. for Fluidigm.Fluidigm Products Simplify Experimental Workflow As a Vendor Partner, Fluidigm will offer preferred pricing on a broad range of instruments, reagents, and assay design services. Fluidigm is the world’s creator of integrated fluidic circuits, a unique microfluidic technology that provides the equivalent of an “integrated circuit for biology.” Fluidigm’s technology enables rapid, efficient and reproducible analysis of hundreds of genetic markers, across thousands of DNA samples – in just hours instead of days or weeks.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts